The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function

Taipei City Hospital57 enrolled

Overview

The aim of the study is to examine whether the Chinese herbal formula (KSY) is effective on HCV Carrier With Abnormal Liver Function.

percentage of change on HCV RNA titer and liver function (GPT).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Liver Function

Interventions

KSYDRUG

Chinese herbal formula

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 40 \< GPT \<200 HCV carrier Age: 18-65 yrs old Exclusion Criteria: * Creatinine \>2.0 mg/dL Total bilirubin \> 2.0mg/dL Not suitable patients diagnosis by physician in charge.

Locations (1)

Taipei City Hospital

Taipei, Taiwan, Taiwan

Outcomes

Primary Outcomes

HCV RNA titer

Time frame: 6 weeks

Secondary Outcomes

Serum GPT level

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.